-
.75mvials
of Artesun® (Guilin Pharma's injectable artesunate) delivered to treat children with severe malaria, saving an estimated additional 450,000 - 500,000 lives compared to quinine treatment
-
.>200,000doses
of Eurartesim® (dihydroartemisinin-piperaquine), co-developed with Sigma-Tau, distributed in two ground-breaking mass drug administration pilots in Zambia and Mozambique
-
.17drug candidates
brought forward from discovery research since 2010
